Washington, D.C. – Today, Senators Richard Blumenthal (D-CT), Amy Klobuchar (D-MN), Kamala Harris (D-CA), and Jeff Merkley (D-OR) introduced the CURE High Drug Prices Act, which would give the Department of Health and Human Services (HHS) the power to stop drug company price gouging for common drugs like insulin. Leslie Dach, chair of Protect Our Care, issued the following statement in response:
“Senators Blumenthal, Klobuchar, Harris and Merkley’s bill takes direct aim at the ability of drug companies to charge excessive prices for common drugs like insulin – a critical issue impacting millions of Americans and they should be commended for their action today. The Trump administration and its Republican allies in Congress gave billions of dollars in tax breaks to big drug companies, and in response, their profits have soared while drug prices have gone through the roof. Voters sent a clear message in the midterm elections: they want Congress to reduce drug prices and take their side – not the side of the drug companies.”